Literature DB >> 8741788

Drinking water and cancer.

R D Morris1.   

Abstract

Any and all chemicals generated by human activity can and will find their way into water supplies. The types and quantities of carcinogens present in drinking water at the point of consumption will differ depending on whether they result from contamination of the source water, arise as a consequence of treatment processes, or enter as the water is conveyed to the user. Source-water contaminants of concern include arsenic, asbestos, radon, agricultural chemicals, and hazardous waste. Of these, the strongest evidence for a cancer risk involves arsenic, which is linked to cancers of the liver, lung, bladder, and kidney. The use of chlorine for water treatment to reduce the risk of infectious disease may account for a substantial portion of the cancer risk associated with drinking water. The by-products of chlorination are associated with increased risk of bladder and rectal cancer, possibly accounting for 5000 cases of bladder cancer and 8000 cases of rectal cancer per year in the United States. Fluoridation of water has received great scrutiny but appears to pose little or no cancer risk. Further research is needed to identify and quantify risks posed by contaminants from drinking-water distribution pipes, linings, joints, and fixtures and by biologically active micropollutants, such as microbial agents. We need more cost-effective methods for monitoring drinking-water quality and further research on interventions to minimize cancer risks from drinking water.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8741788      PMCID: PMC1518976          DOI: 10.1289/ehp.95103s8225

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  34 in total

1.  Results and conclusions of the National Toxicology Program's rodent carcinogenicity studies with sodium fluoride.

Authors:  J R Bucher; M R Hejtmancik; J D Toft; R L Persing; S L Eustis; J K Haseman
Journal:  Int J Cancer       Date:  1991-07-09       Impact factor: 7.396

2.  Relation between carcinoma of the bladder and infestation with Schistosoma haematobium.

Authors:  M Gelfand; R W Weinberg; W M Castle
Journal:  Lancet       Date:  1967-06-10       Impact factor: 79.321

3.  Arsenic and cancers.

Authors:  C J Chen; T L Kuo; M M Wu
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

4.  A case-control study of asbestos in drinking water and cancer risk.

Authors:  L Polissar; R K Severson; E S Boatman
Journal:  Am J Epidemiol       Date:  1984-03       Impact factor: 4.897

5.  A Bayesian analysis or scientific judgment of uncertainties in estimating risk due to 222Rn in U.S. public drinking water supplies.

Authors:  D J Crawford-Brown; C R Cothern
Journal:  Health Phys       Date:  1987-07       Impact factor: 1.316

6.  The use of asbestos-cement pipe for public water supply and the incidence of cancer in selected communities in Utah.

Authors:  T D Sadler; W N Rom; J L Lyon; J O Mason
Journal:  J Community Health       Date:  1984

7.  Cancer mortality in U.S. counties with hazardous waste sites and ground water pollution.

Authors:  J Griffith; R C Duncan; W B Riggan; A C Pellom
Journal:  Arch Environ Health       Date:  1989 Mar-Apr

8.  Asbestos in drinking water and cancer incidence in the San Francisco Bay area.

Authors:  M S Kanarek; P M Conforti; L A Jackson; R C Cooper; J C Murchio
Journal:  Am J Epidemiol       Date:  1980-07       Impact factor: 4.897

9.  Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans.

Authors:  J Whittle; E P Steinberg; G F Anderson; R Herbert
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

10.  p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene.

Authors:  A M Soto; H Justicia; J W Wray; C Sonnenschein
Journal:  Environ Health Perspect       Date:  1991-05       Impact factor: 9.031

View more
  13 in total

1.  Mutagenicity and genotoxicity of drinking water in Guelma region, Algeria.

Authors:  Ahlem Abda; Djamel E Benouareth; Mouna Tabet; Recep Liman; Muhsin Konuk; Messaouda Khallef; Ali Taher
Journal:  Environ Monit Assess       Date:  2015-01-28       Impact factor: 2.513

2.  Cold Climate Is a Risk Factor for Thyroid Cancer.

Authors:  Steven Lehrer; Kenneth E Rosenzweig
Journal:  Clin Thyroidol       Date:  2014-10

3.  Estimating avoidable causes of cancer.

Authors:  D L Davis; C Muir
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

4.  Primary prevention of cancer: needs and opportunities for research.

Authors:  A B Miller
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

Review 5.  Molecular mechanisms of arsenic carcinogenesis.

Authors:  Chuanshu Huang; Qingdong Ke; Max Costa; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 6.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.

Authors:  Miroslav Stýblo; Zuzana Drobná; Ilona Jaspers; Shan Lin; David J Thomas
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

Review 7.  Drinking water disinfection byproducts: review and approach to toxicity evaluation.

Authors:  G A Boorman
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

8.  Occurrence and Control of Genotoxins in Drinking Water: A Monitoring Proposal.

Authors:  Elisabetta Ceretti; Massimo Moretti; Ilaria Zerbini; Milena Villarini; Claudia Zani; Silvano Monarca; Donatella Feretti
Journal:  J Public Health Res       Date:  2016-12-21

9.  Inadequate water treatment quality as assessed by protozoa removal in Sarawak, Malaysia.

Authors:  Nguk Ting Lo; Mohammad Abul Bashar Sarker; Yvonne Ai Lian Lim; Md Harun-Or-Rashid; Junichi Sakamoto
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

Review 10.  Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?

Authors:  Vikram L Sundararaghavan; Puneet Sindhwani; Terry D Hinds
Journal:  Oncotarget       Date:  2017-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.